| |
| |
|
| Insider
Information: |
Bridgebio Pharma Llc |
| Relationship: |
10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,000 |
|
|
Indirect Shares
|
24,575,501 |
|
|
| Direct
Value |
$122,210 |
|
|
|
Indirect Value
|
$3,003,371,977 |
|
|
| Total
Shares |
24,576,501 |
|
|
| Total
Value |
$3,003,494,187 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2021-01-26 |
1,000 |
2019-07-03 |
24,575,501 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2021-01-26 |
4 |
B |
$0.00 |
$0 |
D/D |
14,428,836 |
1,000 |
2.37 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
1.5 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
D/D |
1,103,848 |
23,693,148 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-10 |
4/A |
B |
$13.29 |
$542,063 |
D/D |
40,653 |
22,589,300 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-10 |
4 |
S |
$13.29 |
$542,063 |
D/D |
(40,653) |
22,589,300 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-07 |
4 |
S |
$13.94 |
$576,007 |
D/D |
(41,174) |
22,548,647 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-07 |
4/A |
B |
$13.94 |
$576,007 |
D/D |
41,174 |
22,548,647 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-06 |
4 |
S |
$13.34 |
$519,860 |
D/D |
(38,970) |
22,507,473 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-06 |
4/A |
B |
$13.34 |
$519,860 |
D/D |
38,970 |
22,507,473 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-05 |
4 |
B |
$14.01 |
$15,464,910 |
D/D |
1,103,848 |
22,468,503 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-12-03 |
4 |
B |
$15.50 |
$27,125,000 |
D/D |
1,750,000 |
21,364,655 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-06-22 |
4 |
B |
$17.00 |
$17,000,000 |
D/D |
1,000,000 |
19,614,655 |
2.45 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-06-22 |
4 |
D |
$17.00 |
$3,599,954 |
D/D |
(211,762) |
18,614,655 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
– – • |
2018-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
18,826,417 |
18,826,417 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
